Skip to content

Maternal Polyunsaturated Fatty Acids in Association With Child Autism Spectrum Disorder in the MARBLES Study

Maternal Polyunsaturated Fatty Acids in Association With Child Autism Spectrum Disorder in the MARBLES Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03468959
Enrollment
252
Registered
2018-03-19
Start date
2006-01-31
Completion date
2016-06-30
Last updated
2023-12-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism Spectrum Disorder

Brief summary

This study is to examine the association between maternal omega3 and other polyunsaturated fatty acids (PUFAs) during pregnancy and autism spectrum disorder (ASD) as well as other non-typical development (Non-TD) in the prospective Markers of Autism Risk in Babies-Learning Early Signs (MARBLES) cohort.

Interventions

BEHAVIORALMaternal Supplemental PUFA Intake

Maternal Supplemental PUFA Intake included sources from the questionnaires and plasma

Sponsors

University of California, Davis
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
3 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Mother or father had a biological child with ASD * Mother is at least 18 years old * Mother is pregnant or planning a pregnancy, and biologically able to become pregnant * Mother is living within 2 hours of the MIND Institute * Mother is sufficiently fluent in English

Exclusion criteria

* Mothers with diseases which will influence on their study participation

Design outcomes

Primary

MeasureTime frameDescription
autism spectrum disorder group (ASD)36 monthsnumber of people with ASD

Secondary

MeasureTime frameDescription
A group of typically development (TD) people36 monthsnumber of typically developed people

Other

MeasureTime frameDescription
A group of non-typical development (Non-TD) people36 monthsnumber of people with non-typical development

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026